دورية أكاديمية

1448P First-line nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC): Results from an interim analysis of the non-interventional FINN study

التفاصيل البيبلوغرافية
العنوان: 1448P First-line nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC): Results from an interim analysis of the non-interventional FINN study
المؤلفون: Kuon, J.B., von der Heyde, E., Wilop, S., Behringer, D.M., Blau, W., Huebner, G., Flieger, D., Forstbauer, H., Groschek, M., Laack, H-E., Mueller-Huesmann, H., Schumann, C., Waldenberger, D., Gütz, S.
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S823-S824
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.09.2479